Connect with us

CBD News

Brazil Makes Headway on Medical Marijuana Product Roll-Out Despite Blocking Cannabis Growing

Charnell Lock

Published

on

Brazil Makes Headway on Medical Marijuana Product Roll-Out Despite Blocking Cannabis Growing

Anvisa, a pharmaceutical regulator in Brazil, approved regulations related to the issuance of medical cannabis products, according to a report by Reuters. Further, even though the regulator appears to be making headway on medical cannabis, it blocked a separate vote proposing the allowance of domestic plantations for medical marijuana.

An unnamed spokesperson for Anvisa indicated that if a Brazilian firm is interested in manufacturing cannabis-based products, then inputs would need to be imported from abroad. The prohibition concerning domestic cannabis production is led by President Jair Bolsonaro, according to a report. The report also indicated that he is unwilling to develop a cannabis sector that is fully integrated.

Anvisa also released a statement on the regulatory approval, indicating that the country’s official gazette would publish the new rules in the coming days, and 90 days after the publications, the rules would become law. Anvisa also provided specific rules on the import, manufacture, sale, marketing, packaging, and regulation of medical cannabis-based products.

Charnell Lock lives in sunny San Diego but is originally from North Carolina and has been writing professionally since 2011. After four years with the Navy and an Associate's Degree in Liberal Arts, Charnell found her passion in creating diverse content with well-formatted research. Along with her years in active duty service, she is capable of crafting whimsical short stories to medical-oriented papers as her capacity to contribute here is immense and will be a staple for many years to come.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com